Astrana Health Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
77.5%projected annual EPS growth
Analyst Coverage
8analysts covering
FY Revenue (est.)
$4Bnext fiscal year
Monitoring Framework
Key Performance Indicators
Total Revenue Annually3.2BTarget: 3,800,000,000 to 4,100,000,000
Adjusted EBITDA Annually205.4MTarget: 29% growth at the midpoint
Net Leverage Ratio Quarterly2.3xTarget: At or below 2.0x
Watch Items
- Prospect Health Integration ProgressTrigger: Operational synergies tracking below the $12M-$15M rangeAction: Re-evaluate cost-saving initiatives and standard care protocols across integrated clinics.
- Medicare Advantage Medical Cost TrendTrigger: Actual medical cost trend exceeding the underwritten levelAction: Adjust risk-bearing contract terms and accelerate AI-driven care coordination to optimize utilization.
Research as of 19 Jun 2026